Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45]

• Johanna Kuhlin,
• Marieke G.G. Sturkenboom,
• Samiksha Ghimire,
• Ioana Margineanu,
• Simone H.J. van den Elsen,
• Noviana Simbar,
• Onno W. Akkerman,
• Erwin M. Jongedijk,
• Remco A. Koster,
• Judith Bruchfeld,
• Daan J. Touw,
• Jan-Willem C. Alffenaar

Affiliations

Johanna Kuhlin

Unit of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

Marieke G.G. Sturkenboom

University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands

Samiksha Ghimire

University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands

Ioana Margineanu

University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands

Simone H.J. van den Elsen

University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands

Noviana Simbar

University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands

Onno W. Akkerman

University of Groningen, University Medical Center Groningen, Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands

Erwin M. Jongedijk

University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands

Remco A. Koster

PRA Health Sciences Bioanalytical Laboratory, Assen, The Netherlands

Judith Bruchfeld

Unit of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

Daan J. Touw

University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, Department of Pharmacokinetics, Toxicology and Targeting, Groningen, The Netherlands

Jan-Willem C. Alffenaar

University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands; Corresponding author.